Search - tctmd.com

Displaying 181 - 200 of 234

Sort: Relevancy | Date

Presentation ACC 2017

DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion

Presenter: Seung-Jung Park

March 20, 2017

Presentation ACC 2017

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

Presenter: Pieter Smits

March 20, 2017

News Conference News ACC 2017

DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions

Yael L. Maxwell

March 19, 2017

Presentation ACC 2017

iFR vs FFR for Guiding Coronary Revascularization – DEFINE-FLAIR

Presenter: Justin E Davies

March 19, 2017

Presentation ACC 2017

Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results

Presenter: Stephen G. Ellis

March 19, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Todd Neale

March 18, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Todd Neale

March 18, 2017

News Conference News ACC 2017

People Living in Amazon Rainforest Provide Clues to Coronary Protection

L.A. McKeown

March 17, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Conference News ACC 2017

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

Caitlin E. Cox

March 14, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News ACC 2017

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Michael O'Riordan

March 10, 2017

News Conference News ACC 2017

Down and Out: Depressed CAD Patients Twice as Likely to Die as Those Without Depression

L.A. McKeown

March 09, 2017

News Conference News ACC 2017

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

L.A. McKeown

March 09, 2017

News Conference News ACC 2016

Hints of What’s to Come in New Coronary Revascularization AUC

Caitlin E. Cox

April 12, 2016

News Conference News ACC 2016

CT Angiography and Stress Testing: Prognostic Value Differs Between Women and Men

Caitlin E. Cox

April 08, 2016

News Conference News ACC 2016

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Michael O'Riordan

April 06, 2016

Advertisement

DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions

iFR vs FFR for Guiding Coronary Revascularization – DEFINE-FLAIR

Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

People Living in Amazon Rainforest Provide Clues to Coronary Protection

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Down and Out: Depressed CAD Patients Twice as Likely to Die as Those Without Depression

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

Hints of What’s to Come in New Coronary Revascularization AUC

CT Angiography and Stress Testing: Prognostic Value Differs Between Women and Men

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content